Skip to main content

This April 15, 2017 file photo shows marijuana plants for sale at the ShowGrow dispensary a medical marijuana provider in downtown Los Angeles.

Richard Vogel/AP

Globe editors have posted this research report with permission of Beacon Securities Ltd. This should not be construed as an endorsement of the report's recommendations. For more on The Globe's disclaimers please read here. The following is excerpted from the report:

With a run up expected in Q2/FY18, what may be in store for investors in Q1/FY18? Particularly given the exceptional run in recent weeks, we believe there is a good chance that stocks come in somewhat in Q1/FY18, before going on a run again in Q2/FY18. Some may see that as a welcome and healthy pullback, although, of course it may not happen – particularly given the momentum at the end of 2017 / so far through 2018, and the four imminent multi-LP catalysts we see coming.

Read the full report here.

Story continues below advertisement

Globe app users click here for the full report

Read other research reports here.

Report an error Editorial code of conduct
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter